Session Description: Svetomir N. Markovic, M.D., Ph.D. is Professor of Medicine and Oncology at Mayo Clinic in Rochester, MN, where he holds an appointment in Oncology and is an Associate Professor in the Department of Immunology. He is recognized with distinction as the Charles F. Mathy Professor in Melanoma Research. He is the Chair of the Melanoma Disease Oriented Group of the Mayo Clinic Cancer Center as well as the Chair of the Midwest Melanoma Partnership. With over 230 peer-reviewed publications, his research interests center on translational immunotherapeutics of cancer, from basic science investigations into the mechanisms of tumor-immune interactions to development of novel treatment platforms for patients with advanced cancer, focusing on malignant melanoma and non-Hodgkin's lymphoma. This work includes development and clinical testing of cancer vaccines, nanoparticles, immune-boosting agents, novel agents that reconstitute immunity in patients with cancer, and combination therapy directed at enhancing anti-tumor immune responses. In this presentation, Dr. Markovic and his research team will share their experience with the cyclic multiplex immunofluorescence platform developed by Cytiva (formerly GE Healthcare) as applied to the spatially preserved, metastatic melanoma microenvironment.
